Literature DB >> 24352446

Hepatitis C virus impairs natural killer cell-mediated augmentation of complement synthesis.

Hangeun Kim1, Sandip K Bose, Keith Meyer, Ranjit Ray.   

Abstract

UNLABELLED: Natural killer (NK) cells and the complement system play critical roles in the first line of defense against pathogens. The synthesis of complement components C4 and C3 is transcriptionally downregulated by hepatitis C virus (HCV) core and NS5A proteins, and this negative regulation is apparent in chronically HCV-infected patients. In this study, we have examined the potential contribution of an NK cell line as a model in regulating complement synthesis. Coculture of NK cells (NK3.3) with human hepatoma cells (Huh7.5) expressing HCV core or NS5A protein led to a significant increase in C4 and C3 complement synthesis via enhanced specific transcription factors. Reestablishment of complement protein expression was found to be mediated by direct interaction between NKG2D on NK cells and the hepatocyte protein major histocompatibility complex class I-related chains A and B (MICA/B) and not to be associated with specific cytokine signaling events. On the other hand, C4 and C3 synthesis remained impaired in a coculture of NK cells and Huh7.5 cells infected with cell culture-grown HCV. The association between these two cell types through NKG2D and MICA/B was examined further, with MICA/B expression in HCV-infected hepatocytes found to remain inhibited during coculture. Further experiments revealed that the HCV NS2 and NS5B proteins are responsible for the HCV-associated decrease in MICA/B. These results suggest that HCV disables a key receptor ligand in infected hepatoma cells, thereby inhibiting the ability of infected cells to respond to stimuli from NK cells to positively regulate complement synthesis. IMPORTANCE: The complement system contributes to the protection of the host from virus infection. However, the involvement of complement in viral hepatitis has not been well documented. Whether NK cells affect complement component expression in HCV-infected hepatocytes remains unknown. Here, we have shown how HCV subverts the ability of NK cells to positively mediate complement protein expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24352446      PMCID: PMC3958077          DOI: 10.1128/JVI.02988-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.

Authors:  Masahisa Jinushi; Tetsuo Takehara; Tomohide Tatsumi; Tatsuya Kanto; Takuya Miyagi; Takahiro Suzuki; Yoshiyuki Kanazawa; Naoki Hiramatsu; Norio Hayashi
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

2.  Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

Authors:  J Nattermann; G Feldmann; G Ahlenstiel; B Langhans; T Sauerbruch; U Spengler
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

Review 3.  Innate or adaptive immunity? The example of natural killer cells.

Authors:  Eric Vivier; David H Raulet; Alessandro Moretta; Michael A Caligiuri; Laurence Zitvogel; Lewis L Lanier; Wayne M Yokoyama; Sophie Ugolini
Journal:  Science       Date:  2011-01-07       Impact factor: 47.728

4.  Hepatitis C virus core protein interacts with fibrinogen-beta and attenuates cytokine stimulated acute-phase response.

Authors:  Malika Ait-Goughoulte; Arup Banerjee; Keith Meyer; Budhaditya Mazumdar; Kousuke Saito; Ratna B Ray; Ranjit Ray
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

5.  Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state.

Authors:  Matthew G Lassen; John R Lukens; Joseph S Dolina; Michael G Brown; Young S Hahn
Journal:  J Immunol       Date:  2010-02-01       Impact factor: 5.422

Review 6.  Regulation of interferon-gamma during innate and adaptive immune responses.

Authors:  Jamie R Schoenborn; Christopher B Wilson
Journal:  Adv Immunol       Date:  2007       Impact factor: 3.543

7.  Hepatitis C virus core protein and cellular protein HAX-1 promote 5-fluorouracil-mediated hepatocyte growth inhibition.

Authors:  Arup Banerjee; Kousuke Saito; Keith Meyer; Sutapa Banerjee; Malika Ait-Goughoulte; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

Review 8.  Natural killer cells in liver disease.

Authors:  Zhigang Tian; Yongyan Chen; Bin Gao
Journal:  Hepatology       Date:  2013-04       Impact factor: 17.425

Review 9.  Human natural killer cells.

Authors:  Michael A Caligiuri
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

10.  Hepatitis C virus proteins inhibit C3 complement production.

Authors:  Budhaditya Mazumdar; Hangeun Kim; Keith Meyer; Sandip K Bose; Adrian M Di Bisceglie; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

View more
  14 in total

1.  Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus.

Authors:  Young-Chan Kwon; Hangeun Kim; Keith Meyer; Adrian M Di Bisceglie; Ranjit Ray
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

Review 2.  MICA SNPs and the NKG2D system in virus-induced HCC.

Authors:  Kaku Goto; Naoya Kato
Journal:  J Gastroenterol       Date:  2014-10-01       Impact factor: 7.527

Review 3.  Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers.

Authors:  Tatsuo Kanda; Xia Jiang; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

Review 4.  Hepatitis C Virus Manipulates Humans as its Favorite Host for a Long-Term Relationship.

Authors:  Ratna B Ray; Ranjit Ray
Journal:  Hepatology       Date:  2019-02       Impact factor: 17.425

5.  Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study.

Authors:  Kaku Goto; Dorcas A Annan; Tomoko Morita; Wenwen Li; Ryosuke Muroyama; Yasuo Matsubara; Sayaka Ito; Ryo Nakagawa; Yasushi Tanoue; Masahisa Jinushi; Naoya Kato
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

6.  Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and Immunity.

Authors:  Ming-Ling Chang; Chia-Jung Kuo; Hsin-Chih Huang; Yin-Yi Chu; Cheng-Tang Chiu
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

7.  Prevalence and Incidence of HCV Infection among Prisoners in Central Brazil.

Authors:  Marco Antonio Moreira Puga; Larissa Melo Bandeira; Mauricio Antonio Pompilio; Julio Croda; Grazielli Rocha de Rezende; Luiz Fernando Paiva Dorisbor; Tayana Serpa Ortiz Tanaka; Gabriela Alves Cesar; Sheila Araújo Teles; Simone Simionatto; Alisson Richard Teixeira Novais; Bruna Nepomuceno; Lisie Souza Castro; Barbara Vieira do Lago; Ana Rita Coimbra Motta-Castro
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

Review 8.  Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis.

Authors:  Emma Reungoat; Boyan Grigorov; Fabien Zoulim; Eve-Isabelle Pécheur
Journal:  Cancers (Basel)       Date:  2021-05-09       Impact factor: 6.639

Review 9.  Hepatitis C virus infection: establishment of chronicity and liver disease progression.

Authors:  Young-Chan Kwon; Ratna B Ray; Ranjit Ray
Journal:  EXCLI J       Date:  2014-08-27       Impact factor: 4.068

Review 10.  Viral Evasion of Natural Killer Cell Activation.

Authors:  Yi Ma; Xiaojuan Li; Ersheng Kuang
Journal:  Viruses       Date:  2016-04-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.